Nicolas Barthelemy, President of Cell Systems at Life Technologies said, We’re proud to be recognized and awarded for technology that we believe will fundamentally change the price/performance curve and make high sensitivity and high throughput flow cytometry easily accessible to most researchers. The acoustic nature of Attune represents the biggest change in the flow cytometry industry in thirty years.
Flow cytometry allows scientists to count and examine cells by passing them through a laser-based detection device. Thousands of cells per second may be counted, allowing rapid characterization of entire populations of cells. Cellular biologists engage in flow cytometry for a rapidly growing range of applications, including the study of proteins expressed by cells (immunophenotyping), quantifying the amount of DNA in cells, cell counting, among others.
The commercialization of Attune leverages the company’s expertise in instrumentation, as well as its position as a long-time leading provider of flow cytometry reagents, to create a system that will offer scientists enhanced sample throughput, sensitivity and accuracy for a range of cell biology applications.
In 2007, Life Technologies was also honored with this award for its next-generation genomic analysis SOLiD(TM) System.
For Research Use Only. Not for use in diagnostic procedures.
About Life Technologies (www.lifetechnologies.com)
Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.